Articles by Editor

New Mandibular Advancement Device Provides Dentists with an Innovative 3D-Printed Option to Treat Patients with Sleep Apnea

New West Dental Lab Int…

AdventHealth is taking its Nursing Professional Excellence Program digital with StaffGarden's cloud-based Clinical Ladder Platform Grow

Grow: The Clinical Advancement Platform …

The funding, led by existing investors BioAdvance and Wellness Coaches, follows additional 3rd party studies by University College London and LateralDx, confirming that Senzo's Amplified Lateral Flow (ALF) platform returned greater than 98% accura…

As mental health disorders increasingly impact global populations, Gb Sciences is developing psychotropic but non-psychedelic treatments for anxiety and depression that compete with the emerging billion-dollar psychede…

LEONA VALLEY, Calif. – December 9, 2022 – (Newswire.com)

Leona Val…

After a month dedicated to Cyber Security in October, the situation is now high-risk for many organizations. Cyber attacks are increasing, and the healthcare Industry is often specifically targeted. Whether the breach is due to ransomware attacks or po…

BIRMINGHAM, Ala. – December 8, 2022 – (Newswire.com)

BioGX, a global provider of easy molecular diagnostic solutions since 2007, announced the Ex-US commercial release of its portable pixl™ qPCR real-time PCR platform for use with BioGX CE-IVD marked assays, enabling global access and complementing the recent US FDA EUA expanded use of Xfree™ COVID-19 Direct RT-PCR on the pixl.

The pixl instrument is a benchtop 4-channel, 16-well, RT-PCR instrument that supports rapid turnaround times for batches of up to 16 samples, with integrated results interpretation on a device with the compact footprint of a touchpad.

“pixl, combined with our unique Xfree chemistry, offers a low-cost direct-sample-to-answer PCR solution on a portable, compact device. pixl will provide broader access to clinical laboratories for decentralized PCR testing, enabling faster, better, low-cost near-patient molecular diagnostics,” said Shazi Iqbal, Ph.D., CEO of BioGX.

This platform was previously CE-IVD marked and can be used with the following BioGX CE-IVD marked assays:

• Xfree COVID-19 (N1-gene) Direct RT-PCR
• Xfree COVID-19 (N1/RdRp), Flu A, Flu B
• Xfree Group A Streptococcus

Starting January 2023, BioGX will make additional syndromic tests available on the pixl platform from its large menu of lyophilized multiplex assays, including the Research Use Only (RUO) Direct-Sample assays: Xfree Human Monkeypox (hMPXV), Xfree HSV1/HSV2/VZV and Xfree Treponema pallidum (Syphilis). The Xfree assay format is compatible with most commonly used transport/collection media types and can be validated with a wide variety of patient sample collections. 

Additional information can be requested by contacting BioGX at Ph: +1.205.250.8055 or [email protected]. 

About BioGX

BioGX is a leading global provider of lyophilized real-time PCR reagents for molecular diagnostics. BioGX, Inc., headquartered in Birmingham, Alabama, and Dallas, TX, and its wholly owned subsidiary BioGX B.V., based in Amsterdam, The Netherlands, (collectively “BioGX”), operates in a cGMP compliant environment certified to ISO 13485 medical device development and manufacturing standards. The proprietary Sample-Ready^™ technology is at the core of all product offerings for Clinical, Food Safety, Pharma QC and Water Quality molecular testing. BioGX’s 60+ multiplex real-time PCR products are marketed and sold in several countries through its Global Distribution Network. 

For more information on BioGX, please visit BioGX.com.

Sample-Ready, Just Add Water, Xfree and pixl are trademarks of BioGX, Inc.

Contact Information:

Mohammed Merchant

Sr. Director, Marketing

[email protected]

(205) 250-8055

Press Release Service
by
Newswire.com

Original Source:

BioGX Launches ‘pixl™’ Portable qPCR Platform Ex-US With Expanded Test Menu for Infectious Diseases

Michael Holland as Chief Development Officer, Sampath Narayanan as Chief Information Officer, and Kimberly Shreve as Chief Compliance and Privacy Officer

…

With growing membership numbers, the health insurance alternative boasts medical bill crowdfunding, Care Advocates, and an option to invest in Bitcoin.

…

Aronora co-founder and CEO Dr. Erik Tucker has been elected as Fellow of the National Academy of Inventors (NAI)

Dr. Erik Tucker, CEO of Aronora …